SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016990
Filing Date
2023-05-15
Accepted
2023-05-15 09:25:54
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1066392
2 ex10-2.htm EX-10.2 25105
3 ex31-1.htm EX-31.1 18135
4 ex31-2.htm EX-31.2 18122
5 ex32.htm EX-32 10090
6 ex99-1.htm EX-99.1 33922
7 ex99-1_001.jpg GRAPHIC 5427
  Complete submission text file 0001493152-23-016990.txt   5810091

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE envb-20230331.xsd EX-101.SCH 42260
9 XBRL CALCULATION FILE envb-20230331_cal.xml EX-101.CAL 46707
10 XBRL DEFINITION FILE envb-20230331_def.xml EX-101.DEF 186722
11 XBRL LABEL FILE envb-20230331_lab.xml EX-101.LAB 359523
12 XBRL PRESENTATION FILE envb-20230331_pre.xml EX-101.PRE 279587
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1043785
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 23919006
SIC: 2834 Pharmaceutical Preparations